Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.

1992/04/01 by J T Bruder, Joseph T. Bruder, G Heidecker +3
Biochemistry, Genetics and Molecular Biology · #Cell death mechanisms and regulation #Melanoma and MAPK Pathways #NF-κB Signaling Pathways

paper · pdf · doi:10.1101/gad.6.4.545

openalex publication_date 1992/04/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Abstract

Raf-1 serine-threonine protein kinase has the hallmarks of a critical switch that connects growth factor receptor activation at the cell membrane with transcriptional events in the nucleus. We show by use of Raf-1 dominant-negative mutants that Raf-1 is required for serum-, TPA-, and Ras-induced expression from the oncogene-responsive element in the polyomavirus enhancer. The minimal region of Raf-1 that displays this dominant-negative phenotype (Raf-C4) contains a cysteine finger motif. Raf-C4 appears to function by titrating out a Raf-1-activating factor that is induced by Ras following serum or TPA treatment of NIH-3T3 cells. In addition, we show that Raf-1 and Ras cooperate in trans-activation through the oncogene-responsive element and that the cysteine-rich region is necessary for this effect.

Related

• Analysis of the transcriptional program induced by Raf in epithelial cells
• Regulation of RAF family kinases: new insights from recent structural and biochemical studies
• Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations
• Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
• WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation